KELSEY ST. ARNAUD: Open Payments
NPI 1083370886 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 37 payments from 9 companies in 2025. Trend: 2023 $71 · 2024 $63 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $170 |
| ABBVIE INC. | 9 | $139 |
| Lilly USA, LLC | 4 | $72 |
| Dexcom, Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 1 | $33 |
| Exact Sciences Corporation | 2 | $29 |
| Amgen Inc. | 1 | $14 |
Products named: Rybelsus, MOUNJARO, Dexcom G6 Transmitter, VOQUEZNA, PIFELTRO, Ozempic, VRAYLAR, QULIPTA.
Industry payments across LA — which companies pay providers there.
